Back to Articles
98802027 Q1PrimeJGAAP

INNOTECH CORPORATION FY2027 Q1 Earnings Report

INNOTECH CORPORATION FY2027 Q1 earnings report and financial analysis

INNOTECH CORPORATION

Electric Appliances & Precision Instruments/Electric Appliances


Quick View

MetricCurrent PeriodSame Period of Previous YearYoY
Revenue¥14.0B¥9.46B+48.0%
Operating Income¥1.61B¥0.23B+584.7%
Ordinary Income¥1.71B¥0.41B+320.7%
Net Income¥1.23B¥0.19B+562.5%
ROE4.6%0.7%-

Executive Summary

This quarter saw revenue and profit growth, with profitability improving substantially, primarily driven by the rapid expansion of the Test Solutions Business. Revenue was ¥14.0B (¥9.46B in the previous year, +48.0%), Operating Income was ¥1.61B (¥0.23B in the previous year, +584.7%), Ordinary Income was ¥1.71B (¥0.41B in the previous year, +320.7%), and Net Income was ¥1.23B (¥0.19B in the previous year, +562.5%). The gross margin improved to 32.9%, and economies of scale exceeding the increase in revenue contributed to margin expansion.

Factors Affecting Performance

【Revenue】Revenue was ¥14.0B, representing a year-on-year increase of +48.0%. By segment, Test Solutions showed the largest growth at ¥6.18B (44.1% of total revenue, YoY +131.3%), driving company-wide growth. Systems & Services generated ¥4.10B (29.3% of total revenue, YoY +16.5%), while Semiconductor Design-Related Business generated ¥3.72B (26.6% of total revenue, YoY +13.5%); both posted double-digit revenue growth, indicating broad-based growth.

【Profit and Loss】Operating Income was ¥1.61B (YoY +584.7%), and the Operating Income margin improved substantially to 11.5% from 2.5% in the previous year. Operating Income from Test Solutions was ¥1.02B (16.5% margin), accounting for more than half of company-wide profit. The shift in sales mix toward high-margin projects amplified operating leverage. In non-operating items, foreign exchange gains of ¥0.18B boosted Ordinary Income, which reached ¥1.71B (YoY +320.7%). Net extraordinary income and losses were a minor ¥0.005B, and the impact of temporary factors was limited. Net Income of ¥1.23B reflects taxes and other expenses, resulting in earnings growth accompanied by revenue growth.

Segment Analysis

Test Solutions was the largest growth and profit driver, with revenue of ¥6.18B (YoY +131.3%) and Operating Income of ¥1.02B (YoY +486.7%, 16.5% margin). Systems & Services achieved stable growth, with revenue of ¥4.10B (YoY +16.5%) and Operating Income of ¥0.54B (YoY +32.8%, 13.2% margin). Semiconductor Design-Related Business had revenue of ¥3.72B (YoY +13.5%) and Operating Income of ¥0.20B (YoY +45.3%, 5.5% margin). Although it had the lowest margin among the three businesses, it secured profit growth. Margins ranked in the order of Test Solutions, Systems & Services, and Semiconductor Design-Related Business, with the shift in revenue mix toward high-margin businesses serving as the primary factor behind the improvement in the company-wide margin.

Key Financial Metrics

【Profitability】The Operating Income margin was 11.5%, improving by +902bp from 2.5% in the previous year, while the Net Income margin also expanded to 8.8% from 2.0% in the previous year. The gross margin improved by +320bp to 32.9% from 29.7% in the previous year, with the higher margins in Test Solutions generating a mix effect across the company.【Cash Quality】Accounts receivable and notes receivable were high at ¥15.28B, while inventories stood at ¥6.09B, indicating significant working capital tied up in operations. Customer advances of ¥7.73B are functioning as a buffer for liquidity.【Investment Efficiency】ROE was 4.6%. Against the sharp increase in Net Income, net assets of ¥26.70B remain somewhat large, and improvements in capital efficiency are still in progress.【Financial Soundness】The Equity Ratio declined to 54.1% from 56.5% in the previous year but remains at a high level. Short-term borrowings increased by +71.0% year on year to ¥5.34B, highlighting the short-term concentration of interest-bearing debt.

Cash Flow Analysis

As detailed disclosure of the cash flow statement is not provided in this document, cash trends are analyzed based on changes in the balance sheet. Cash and deposits declined to ¥7.40B from ¥8.53B in the previous year, and the accumulation of working capital, including accounts receivable and notes receivable of ¥15.28B and inventories of ¥6.09B, may have absorbed cash. Meanwhile, short-term borrowings increased by +71.0% to ¥5.34B, and customer advances also increased to ¥7.73B, suggesting that funding needs associated with business expansion are being covered through short-term financing and customer advances. Corporate taxes payable declined substantially, and the elimination of a temporary cash outflow resulting from the normalization of prior-period tax payments also appears to have affected cash trends.

Quality of Earnings

The earnings growth was centered on a substantial increase in Operating Income, indicating a strong element of recurring earnings improvement. Of the ¥0.25B in non-operating income, foreign exchange gains accounted for ¥0.18B, equivalent to approximately 11% of Operating Income of ¥1.61B. While this was one factor supporting Ordinary Income, the improvement in the core business was the main contributor. Extraordinary income totaled ¥0.002B and extraordinary losses ¥0.005B, resulting in an almost negligible net amount; the impact of temporary factors on the results was limited. The difference between Ordinary Income of ¥1.71B and Net Income of ¥1.23B was attributable to income taxes and other expenses of ¥0.48B, which is within the range of normal tax burdens. Given the high levels of accounts receivable and inventories, the timing of cash conversion from earnings should be monitored going forward.

Earnings Forecast and Guidance

The full-year plan calls for Revenue of ¥51.0B (YoY +9.1%), Operating Income of ¥4.00B (YoY +28.7%), and Ordinary Income of ¥4.00B (YoY +37.4%). Progress in Q1 was 27.4% for Revenue, 40.2% for Operating Income, and 42.9% for Ordinary Income, with progress at the operating and ordinary income levels substantially exceeding the quarterly benchmark of 25%. The strong start in Test Solutions and the contribution from foreign exchange gains appear to have boosted first-half progress, suggesting that the full-year plan may incorporate a degree of conservatism. Although the earnings forecast was revised during the quarter, there was no revision to the dividend forecast.

Shareholder Returns

The annual dividend forecast is ¥130.00 (including an ordinary dividend of ¥80 and a special dividend of ¥50), representing an increase from the previous year's dividend of ¥35. The breakdown of the year-end dividend for the fiscal year ending March 2026 is an ordinary dividend of ¥40 and a special dividend of ¥50, and the same breakdown is planned for the Q2-end dividend for the fiscal year ending March 2027. Based on the company's forecast EPS of ¥415.47, the Payout Ratio is approximately 31.3%. Given the financial foundation, including cash and deposits of ¥7.40B and an Equity Ratio of 54.1%, concerns regarding the sustainability of shareholder returns appear limited.

Risk Factors

  1. Dependence on short-term liabilities: Short-term borrowings were ¥5.34B, an increase of +71.0% from the previous year, with the majority of interest-bearing debt concentrated in short-term liabilities. Cash of ¥7.40B exceeds short-term borrowings, but refinancing costs could increase in an environment of rising interest rates.

  2. Working capital tied up: Accounts receivable and notes receivable of ¥15.28B and inventories of ¥6.09B indicate substantial asset accumulation. Delays in improving collection and inventory efficiency could affect liquidity.

  3. Sensitivity to foreign exchange and demand fluctuations: Foreign exchange gains of ¥0.18B, which contributed to Ordinary Income, could reverse depending on market conditions. In addition, the rapid growth of the Test Solutions Business is structurally vulnerable to fluctuations in semiconductor market conditions.

Industry Benchmark (For Reference; Company Analysis)

Industry Benchmark (manufacturing)

Profitability and Returns

MetricCompanyMedian (IQR)Delta
Operating Income Margin11.5%8.7% (4.2%–14.2%)+2.8pt
Net Income Margin8.8%7.0% (3.2%–10.6%)+1.7pt

Both the Operating Income margin and Net Income margin exceed the industry median, placing profitability relatively high within the industry.

Growth and Capital Efficiency

MetricCompanyMedian (IQR)Delta
Revenue Growth Rate (Year-on-Year)48.0%6.2% (-1.1%–14.6%)+41.8pt

The Revenue growth rate substantially exceeds both the industry median and the upper bound of the IQR, indicating exceptional growth within the industry.

Source: Company analysis

Key Takeaways from the Earnings Report

  1. The higher margins in the Test Solutions Business are driving the company-wide margin upward. With the business expanding to 44.1% of total revenue, the sustainability of its growth will determine future profitability.

  2. Progress toward the full-year plan exceeds 40% for both Operating Income and Ordinary Income. While this may include first-half weighting or a temporary contribution from foreign exchange gains, Revenue progress is a standard 27.4%.

  3. The high levels of accounts receivable of ¥15.28B and inventories of ¥6.09B are occurring alongside an increase in short-term borrowings (+71.0%), indicating changes in working capital and the funding structure accompanying business expansion.

Theoretical Share Price (Reference Value)

ScenarioTheoretical Share Price
bear (bearish)¥2,825
base (base case)¥2,934
bull (bullish)¥3,075
Valuation AssumptionValue
Book Value Per Share (BPS)¥2,218
Adjusted Forecast EPS¥448.6
Cost of Equity r9.77% (10-year JGB 2.77% + equity risk premium 6.00% + size premium 1.00%)
Persistence Parameter for Residual Income ω / Explicit Forecast Period0.62 / 5 years
Assumed Payout Ratio31.3%
Forecast EPS Confidence Adjustment×1.080 (based on the track record of guidance achievement in the same industry)
Implied PBR / PER1.32x / 6.5x

Sensitivity: ¥2,851–¥3,022 at ±1% for the cost of equity, and ¥2,916–¥2,962 at ±0.1 for ω.

Notes:

  • Net assets as of the quarter-end are used (there is a timing difference from the full-year forecast).
  • As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated using only publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, nor does it predict or guarantee future share prices.)


This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with a professional as necessary.

---End of Report---


AI Financial Analysis

Executive Summary

Innotech delivered an exceptionally strong FY2027 Q1, with the result led by a sharp recovery in the Test Solution business and broad-based margin expansion. Revenue rose 48.0% year on year to ¥14.00bn. Operating income surged 584.7% to ¥1.61bn. Profit attributable to owners of parent increased 549.7% to ¥1.21bn. The operating margin expanded to 11.5% from 2.5% a year earlier, a 902bp improvement. Gross margin rose to 32.9% from 29.6%, an expansion of approximately 321bp. This indicates that the earnings upswing was not solely volume-driven, but also reflected a substantially better sales mix and/or product profitability. SG&A expenses increased 16.4%, materially below revenue growth, producing strong operating leverage. Test Solution revenue more than doubled and its segment result swung from a loss to a substantial profit. System & Service and Semiconductor Design-related businesses also recorded profit growth and margin improvement. Ordinary income rose 320.7% to ¥1.71bn, although it was supported by ¥0.18bn of foreign-exchange gains. Profit before tax was ¥1.71bn and profit attributable to owners was ¥1.21bn, implying a normal 29.5% effective tax burden at the owners' profit level. The annualized ROE was 18.1%, exceeding the 15% threshold generally associated with strong capital efficiency. Liquidity remains sound, with a 172.7% current ratio and cash exceeding short-term borrowings. However, the working-capital cycle is long, with annualized DSO of 100 days, annualized DIO of 92 days, and an annualized cash-conversion cycle of 157 days. The company has raised its full-year forecast, but the first-quarter operating-income progress of 40.2% is substantially ahead of the standard 25% pace and makes the sustainability and timing of Test Solution shipments central to the full-year outlook.

Profitability Analysis

The reported annualized ROE of 18.1% decomposes into an 8.6% net profit margin, 1.133x asset turnover, and 1.85x financial leverage. The principal driver of the strong return profile is profitability: the 8.6% net margin follows an 11.5% EBIT margin and a 32.9% gross margin. The operating margin increased by 902bp year on year, far exceeding the increase implied by financial leverage, and therefore represents the most important change in the DuPont framework. Gross-margin expansion of approximately 321bp and SG&A growth of only 16.4% versus 48.0% sales growth demonstrate favorable operating leverage. The Test Solution business was the core business by segment-profit contribution, generating ¥1.02bn of segment profit, or 57.9% of aggregate segment profit before corporate-cost adjustments. Its revenue grew 131.3% to ¥6.18bn and its segment margin improved to 16.5% from negative 9.9% in the prior-year quarter. Semiconductor Design-related revenue increased 13.5% to ¥3.72bn, while segment profit rose 45.3% to ¥0.20bn and margin improved to 5.5% from 4.3%. System & Service revenue increased 17.0% to ¥4.10bn, while segment profit rose 32.8% to ¥0.54bn and margin improved to 13.2% from 11.6%. The Test Solution margin is now the highest among the reported segments and is the key determinant of consolidated earnings volatility. The tax burden factor of 0.705 is broadly normal, while the interest-burden factor of 1.063 reflects net non-operating income rather than an interest-cost drag. The annualized ROA, calculated using annualized Q1 profit attributable to owners and average total assets, is approximately 9.9%, indicating robust asset returns but remaining dependent on the durability of the quarterly profit level. JGAAP goodwill of ¥0.74bn is only 2.8% of equity, so goodwill amortization and impairment exposure do not appear material to the current profit profile.

Growth Assessment

Growth was led by Test Solution, where tester revenue increased to ¥3.25bn from ¥0.55bn and STAr Technologies revenue increased to ¥2.93bn from ¥2.12bn. This concentration means the exceptional consolidated growth rate is linked primarily to project, customer-order, and shipment timing in semiconductor test-related activity. Semiconductor Design-related growth was more moderate but positive, with EDA and related revenue rising to ¥2.60bn from ¥2.26bn. System & Service growth was also positive, supported by embedded-system and related revenue increasing to ¥1.73bn from ¥0.91bn. The diversity of segment growth is constructive, although profit acceleration was overwhelmingly concentrated in Test Solution. The company forecasts full-year revenue of ¥51.0bn, up 9.1% year on year; Q1 revenue represents 27.4% of this target, modestly above the standard 25% progress rate. Full-year operating income is forecast at ¥4.0bn, up 28.7% year on year; Q1 progress is 40.2%, 15.2 percentage points above the standard pace. Ordinary-income progress is 42.9% against the ¥4.0bn full-year forecast, also well ahead of a typical first-quarter run rate. Profit attributable to owners represents 24.1% of the ¥5.0bn full-year forecast, broadly consistent with the standard 25% pace despite the operating-profit outperformance. The difference between operating and net-profit progress suggests that the full-year earnings path incorporates items below operating income, including the variability of foreign exchange and tax effects. The revised guidance signals management confidence, but the implied remaining-quarter operating margin is lower than the Q1 margin, indicating that management does not extrapolate the first-quarter Test Solution profitability in full.

Financial Health

Balance-sheet liquidity is sound, with current assets of ¥36.28bn against current liabilities of ¥21.01bn, resulting in a current ratio of 172.7%. The quick ratio of 143.7% indicates that liquid assets excluding inventories also cover current liabilities comfortably. Working capital is ¥15.27bn, providing a meaningful near-term liquidity buffer. Interest-bearing debt totals ¥6.29bn, equivalent to a moderate 0.85x debt-to-equity ratio and 19.1% debt-to-capital ratio. These leverage measures are below the 2.0x D/E and 40% debt-to-capital caution thresholds. Cash and deposits of ¥7.40bn equal 1.38x short-term debt, which supports refinancing flexibility. However, ¥5.34bn, or 84.9% of interest-bearing debt, is short-term, creating a material refinancing and maturity-concentration risk. Short-term loans increased 71.0% year on year, or ¥2.22bn, to ¥5.34bn. The increase in short-term funding coincides with a larger receivables balance and advances received, consistent with increased operating scale but requiring disciplined working-capital funding. Current assets exceed current liabilities, so there is no immediate maturity mismatch; nevertheless, the short debt tenor leaves the company more exposed to bank-funding conditions and business-cycle volatility than the aggregate liquidity ratios alone suggest. Total equity declined 1.5% year on year to ¥26.70bn, while the equity ratio declined to 52.6% from 54.8%, though capitalization remains sound. Goodwill represents only 1.5% of total assets and 2.8% of equity, limiting balance-sheet dependence on acquired-value retention.

Notable B/S Changes

Short-term loans: +¥2.22bn (+71.0%) to ¥5.34bn - increased dependence on short-term funding; refinancing risk is heightened because 84.9% of interest-bearing debt is short-term. Advances received: +¥1.57bn (+25.6%) to ¥7.73bn - customer prepayments provide partial funding support for the expanding operating cycle. Treasury stock: -¥0.59bn (+21.9% in absolute balance) to -¥3.31bn - reflects a larger deduction from equity and should be considered when assessing capital allocation. Total equity: -¥0.42bn (-1.5%) to ¥26.70bn - capitalization remains solid, but equity declined despite strong Q1 comprehensive income.

Cash Flow Quality

The earnings profile should be assessed alongside the elevated working-capital commitment embedded in the current balance sheet. Trade receivables increased ¥1.95bn year on year to ¥15.28bn, and electronically recorded monetary claims were ¥0.21bn. Annualized DSO of 100 days exceeds both the 60-day warning level and the 45-day efficiency benchmark. This is a quality concern because a large share of reported Q1 revenue remains uncollected at quarter end. Inventories were ¥6.09bn, with raw materials of ¥1.96bn and work in process of ¥1.44bn. Annualized DIO of 92 days is slightly above the 90-day warning level, creating inventory-carrying and demand-normalization risk. Finished goods account for the reported inventory balance and should be monitored closely in light of the semiconductor-test exposure. The annualized cash-conversion cycle of 157 days is well above the 120-day warning threshold. The combination of high DSO, elevated DIO, and a long cash-conversion cycle can absorb cash even when accounting earnings and gross margins are strong. Accounts payable were ¥3.63bn, while advances received increased ¥1.57bn year on year to ¥7.73bn, partly offsetting the funding burden associated with receivables and inventory. The long cycle is more consistent with the company’s project- and equipment-related revenue characteristics than with a rapid cash retail model, but it remains a material monitoring point. Foreign-exchange gains of ¥0.18bn represented 12.7% of operating income and contributed to non-operating income, so this portion of pre-tax earnings is less recurring than operating profit. Extraordinary items were immaterial, with a ¥0.05bn loss on sale and retirement of noncurrent assets, supporting the view that the principal earnings improvement was operational rather than driven by extraordinary gains.

Dividend Sustainability

The full-year dividend forecast is ¥130 per share. Against forecast EPS of ¥415.47, the implied dividend payout ratio is approximately 31.3%. This is comfortably below the 60% sustainability benchmark and leaves substantial retained capacity for working-capital needs, investment, and debt management. The planned interim dividend includes a ¥40 ordinary dividend and a ¥50 special dividend. The special-dividend component means the indicated distribution is partly linked to the current earnings environment rather than representing a fully recurring base dividend. Q1 EPS was ¥99.37, and the earnings trajectory must remain strong through the balance of the year to support the full-year ¥130 dividend without relying on balance-sheet resources. Cash deposits of ¥7.40bn exceed short-term loans, supporting near-term payment capacity. Nevertheless, the long annualized cash-conversion cycle and high short-term-debt ratio mean dividend cash coverage should be considered in conjunction with collections and inventory normalization. Treasury shares total 1.67 million shares, but no current-period buyback amount is provided; the analysis therefore uses the dividend-only payout ratio rather than a total return ratio.

Risk Assessment

Business risks include Semiconductor-cycle and customer-concentration risk: Test Solution generated ¥6.18bn of revenue and ¥1.02bn of segment profit, making consolidated growth and profitability highly sensitive to tester and STAr Technologies shipment timing., Working-capital and inventory risk: annualized DSO of 100 days, DIO of 92 days, and a 157-day cash-conversion cycle create exposure to delayed customer acceptance, collection delays, inventory obsolescence, or order cancellations., Foreign-exchange risk: FX gains of ¥0.18bn accounted for 12.7% of operating income, showing that exchange-rate movements can materially affect earnings below the operating line., Technology and product-cycle risk: semiconductor test, EDA, embedded systems, and software-related businesses require continued product relevance amid rapid customer technology transitions and competitive pressure., Execution risk: the Test Solution segment moved from a ¥0.26bn loss to a ¥1.02bn profit; preserving this margin requires continued delivery execution, procurement discipline, and favorable product mix..

Financial risks include Refinancing risk is elevated because 84.9% of interest-bearing debt is short-term, well above the 40% alert threshold. Although cash covers short-term debt by 1.38x and current liquidity is healthy, the maturity structure increases exposure to lender terms and short-term funding-market conditions., Short-term loans increased 71.0% year on year to ¥5.34bn. This suggests greater reliance on short-tenor funding as operating scale and working-capital requirements expanded., Receivables collection risk is elevated because annualized DSO of 100 days exceeds the 60-day warning threshold. A deterioration in customer payment behavior would pressure liquidity and potentially increase credit-loss exposure., Inventory funding risk is elevated because annualized DIO of 92 days exceeds the 90-day warning threshold. Excess or slow-moving inventory would tie up capital and may ultimately require valuation adjustments..

Key concerns include Highest priority: whether Q1 Test Solution revenue and its 16.5% segment margin are repeatable, given that Q1 operating-income progress is already 40.2% of the full-year forecast., High priority: conversion of receivables and inventories into cash, as the annualized 157-day cash-conversion cycle is materially above the 120-day warning level., Medium priority: refinancing discipline and the future mix of short-term versus longer-term borrowings following the ¥2.22bn year-on-year increase in short-term loans., Medium priority: the degree to which full-year ordinary income depends on foreign-exchange gains rather than operating performance., Lower priority: goodwill impairment risk is limited currently because goodwill is only 2.8% of equity..

Investment Implications

Key takeaways include Q1 demonstrated a substantial operational recovery: revenue increased 48.0%, operating income increased 584.7%, and operating margin improved 902bp to 11.5%., Test Solution is the core earnings engine, contributing 57.9% of aggregate segment profit before corporate-cost adjustments and recording a 16.5% segment margin., The profitability improvement appears operationally supported by higher gross margin and favorable SG&A leverage, rather than by extraordinary gains., The company’s revised full-year operating-income forecast remains conservative relative to Q1 progress, but this also implies management expects a normalization from the exceptional first-quarter run rate., Liquidity and overall leverage are healthy, but short-term debt concentration and working-capital intensity elevate cash-management importance., The forecast ¥130 dividend implies a moderate 31.3% payout ratio based on forecast EPS, although the special-dividend component should be distinguished from recurring ordinary dividends..

Metrics to watch include Test Solution quarterly revenue, segment margin, tester shipments, and STAr Technologies sales., Consolidated gross margin and SG&A-to-sales ratio as indicators of mix durability and operating leverage., Receivable collections and annualized DSO relative to the current 100-day level., Inventory balance, product mix, and annualized DIO relative to the current 92-day level., Cash-conversion-cycle movement relative to the current annualized 157 days., Short-term-loan balance, refinancing terms, and the proportion of debt with short maturities., Foreign-exchange gains or losses relative to operating income., Achievement of the ¥51.0bn revenue, ¥4.0bn operating-income, and ¥5.0bn profit-attributable-to-owners forecasts..

Regarding relative positioning, Innotech currently combines strong annualized ROE of 18.1%, an 11.5% operating margin, conservative aggregate leverage, and limited goodwill exposure. Its relative weakness is cash efficiency: the 100-day annualized DSO, 92-day annualized DIO, and 157-day annualized cash-conversion cycle are materially weaker than standard manufacturing working-capital benchmarks. The company is therefore positioned as a high-profitability, semiconductor-exposed technology and solutions provider whose valuation-relevant operating performance depends on the repeatability of a very strong Test Solution quarter and on conversion of earnings into cash.